$20.260
+0.162 (+0.80%)收盘时
MMED 资讯
MMED 事件
Stock Futures Weaker as Oil Prices Rise Above $90
Stock futures are pointing to a weaker open as investors begin September facing a renewed combination of geopolitical risk, higher oil prices and rising Treasury yields. Notably, ISM manufacturing data and the July JOLTS report are both due at 10 a.m. ET.Brent crude has climbed back above $90 a barrel, reviving concerns that an extended disruption to energy supplies could push inflation higher. At the same time, the 10-year Treasury yield climbed to roughly 4.75%, creating another headwind for equity valuations, particularly the high-growth technology and AI stocks that have driven much of this year's rally.In pre-market trading, S&P 500 futures fell 0.67%, Nasdaq futures fell 1.31% and Dow futures fell 0.64%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -Fervo Energyup 14% after entering a 396-megawatt power purchase agreement with Googleto enable the continued development of the Cape Station enhanced geothermal systems GeoClusterNovartisup 6% after reporting topline results from its Phase 3 Remodel-1/-2 trials of remibrutinib in relapsing multiple sclerosisRobinhoodup 1% after Morgan Stanley upgraded the stock to Overweight with a price target of $150, up from $124UP AFTER EARNINGS -Regisup 3%Medtronicup 2%DOWN AFTER EARNINGS -MiniMeddown 7%LOWER -Microndown 2% afterMicron Taiwan announced that it will distribute record bonuses to its employees as the company's labor union plans a strikeCharterdown 1% after announcing that Jessica Fischer will step down from her current position as the company's CFO on October 15Niodown 1% after announcing it delivered 35,836 vehicles in August, nearly flat from July
MiniMed Reports Q1 Revenue of $843M
Reports Q1 revenue $843M, consensus $828.43M. "MiniMed delivered an excellent start to our fiscal year, with accelerating U.S. growth, continued double-digit international growth, and strong execution across our innovation pipeline," said MiniMed CEO Que Dallara. "The U.S. launch of MiniMed Flex(TM) is doing exactly what we designed it to do: bringing new patients into the MiniMed ecosystem, driving competitive conversions, and generating significant new account growth. As our ecosystem continues to come together, we are well positioned to accelerate growth, strengthen our leadership in automated insulin delivery, and create long-term shareholder value."
MiniMed Announces New Product Launch
MiniMed (MMED) announced…
MiniMed Launches New Flex System for More Diabetes Patients
MiniMed announced that Medicare and Medicare Advantage beneficiaries now have access to the MiniMed Flex system with its latest sensor portfolio. This milestone now makes the company's smallest and only app-controlled insulin pump system available to more people living with diabetes. Designed to fit more naturally into everyday life, MiniMed Flex helps reduce the daily burden of diabetes management so people can focus more on the moments that matter to them. MiniMed Flex is about half the size of previous MiniMed pumps and roughly the size of two stacked insulin vials, offering a sleek, compact design while still holding 300 units of insulin. Powered by the same SmartGuard technology of the MiniMed 780G system, this system automatically adjusts insulin delivery every five minutes, day and night.
MiniMed Expands Board to 11 Members
MiniMed announced that David Endicott and Linnea Burman have joined its Board of Directors, effective June 29, expanding the Board from nine to 11 members. Endicott will serve as a member of the Board's Compensation and Talent Committee.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。








